Home>Topics>Companies>Johnson & Johnson

Johnson & Johnson JNJ

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
    1. The World’s Dumbest Idea

      Headlines

      Thu, 18 Dec 2014

      altogether different perspective, Johnson & Johnson . In contrast to IBM’s transient objectives, Johnson & Johnson has stuck with a mission statement ..... Whilst IBM targeted SVM, Johnson & Johnson thought shareholders should get

    2. Galapagos loses partner on inflammatory bowel drug

      Headlines

      Tue, 16 Dec 2014

      BRUSSELS, Dec 16 (Reuters) - Belgian biotech group Galapagos said on Tuesday that its research partner Janssen Pharmaceutica, a unit of Johnson & Johnson , had pulled out of a programme to develop a new drug to treat bowel disease.

    3. Ultimate Stock-Pickers: Top Holdings of Top-Performing Managers

      Headlines

      Tue, 16 Dec 2014

      Medium 10,061 3 PepsiCo PEP 2 Wide 94.74 1.05 Low 139,506 3 TJX TJX 3 Narrow 65.61 0.96 Medium 45,206 2.9 J & J JNJ 2 Wide 104.43 1.05 Low 286,039 2.9 Stock Price and Morningstar Rating data as of 12-12-14. After failing

    4. Novartis psoriasis drug tops J & J's Stelara in late-stage study

      Headlines

      Fri, 12 Dec 2014

      ZURICH, Dec 12 (Reuters) - Novartis said on Friday its experimental psoriasis drug Cosentyx was better at clearing the rough skin patches associated with the disease than Johnson & Johnson 's Stelara.

    5. New to Dividend Growth Investing

      Commentary

      Wed, 10 Dec 2014

      OPEC decision. So - here is what I have: Aapl, AEP, APU, CVX, CSCO, CLX, KO, DVN, ETN, GE, GSK, HCN, HSBC, JNJ , KMI, MCD, OXY, O, PM, PG, RCI, SEP, SO, TGT, UPS, UL, and WFC So far so good. I have a 3.5% yield for the

    6. U.S. appeals court tosses $176 mln award for Covidien in patent case

      Headlines

      Thu, 4 Dec 2014

      Dec 4 (Reuters) - The top U.S. patent appeals court has thrown out a $176 million award for healthcare company Covidien Plc in a dispute with a Johnson & Johnson subsidiary over surgical instruments.

    7. Exclusive: J & J hires Goldman to explore sale of Splenda - sources

      Headlines

      Wed, 3 Dec 2014

      NEW YORK/LONDON (Reuters) - U.S. healthcare company Johnson & Johnson has hired Goldman Sachs to explore a sale of its artificial sweetener brand Splenda, sources familiar with the matter told Reuters.

    8. Crucial Facts When Evaluating Unmanaged Vs. Managed Funds

      Headlines

      Tue, 2 Dec 2014

      the highest allocations to stocks with largest market capitalizations, such as Apple, Exxon Mobil, Microsoft, Johnson & Johnson , and General Electric. Right now, the performance of these 5 stocks alone will account for about 11% of how the

    9. Montier: Shareholder Value Maximization ‘The World’s Dumbest Idea’

      Headlines

      Tue, 2 Dec 2014

      altogether different perspective, Johnson & Johnson . In contrast to IBM’s transient objectives, Johnson & Johnson has stuck with a mission statement ..... Whilst IBM targeted SVM, Johnson & Johnson thought shareholders should get

    10. Ultimate Stock-Pickers: Top 10 Buys and Sells

      Headlines

      Tue, 2 Dec 2014

      America BAC replacing wide-moat Johnson & Johnson JNJ , and wide-moat Comcast CMCSA ..... narrow-moat rated Apple AAPL. Both Johnson & Johnson and Apple made our list of ..... CH Robinson Worldwide CHRW, Johnson & Johnson JNJ , GlaxoSmithKline GSK, and

    « Prev12345Next »
    Content Partners